Avita Medical Inc. (RCEL)
NASDAQ • Healthcare
Last close at October 23, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Avita Medical Inc. currently loses $35.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 5
in 11 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Avita Medical beat expectations on both the top and bottom line in the second fiscal quarter of 2026, reported August 6, 2026, with revenue rising 17.8% to about $21.7 million on its RECELL wound-care and skin-restoration platform. On consensus, revenue of $21.7 million topped the $20.2 million estimate, +7%, while EPS of -$0.25 topped the -$0.29 estimate by $0.04, improving from -$0.38 a year ago (+34.2% YoY). Gross profit came in around $17.8 million, with gross margin at about 82%, and operating margin was -31.6% as operating income was roughly -$6.9 million. Net income was about -$7.7 million, narrowing from roughly -$9.9 million a year ago (+22.8% YoY). The company posted negative operating cash flow of around $3.5 million for the quarter. For the next period, consensus calls for EPS of -$0.24 on revenue of $22.4 million.
Next report — what to expect
Avita Medical Inc. (RCEL) reports on November 5, 2026. Consensus calls for EPS of -$0.239 on revenue of $22.4 million. For trailing context, revenue grew +17.8% year over year last quarter. The company has beaten EPS in 1 of 8 most recent quarters, setting a notable watch point versus expectations.
About Avita Medical Inc.
Avita Medical Inc. develops and sells wound-care and skin-restoration devices on NASDAQ as RCEL, operating in medical devices within healthcare. Its RECELL platform and related matrices are used in hospital and treatment-center settings, and the company generated $71.6 million of revenue in FY2025.
Today's Snapshot
RCEL closed 0.6% above yesterday's close, outperforming a weaker sector. At the close, RCEL was within 1.1% of its 52-week high of 15.68. RCEL is due to report earnings on 5 November.
Trading Volume
Below 10d avg (441.8K)
395.4K
vs S&P 500 Today
Outperforming Market
+1.10%
Updated: October 23, 2026 at 20:09 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$7.24 - $14.19Buy
- RSI (14)78.81Sell
- Stochastic %K (14, 3, 3)92.42Sell
- MACD Level (12, 26)1.06Buy
Peers & Related Assets
Get premium market insights delivered directly to your inbox.